Unmistakable Morphology? Infantile Malignant Osteopetrosis Resembling Juvenile Myelomonocytic Leukemia in Infants - 23/07/15
Doi : 10.1016/j.jpeds.2015.04.064
Anne Strauss, MD 1, ⁎ 
, Ingrid Furlan, MD 2, Sandra Steinmann 2, Bernd Buchholz, PhD 3, Bernhard Kremens, MD 4, Claudia Rossig, MD 5, Selim Corbacioglu, MD 6, Revathi Rajagopal, MD 7, Georgia Lahr, PhD 2, Ayami Yoshimi 1, Brigitte Strahm, MD 1, Charlotte M. Niemeyer, PhD 1, Ansgar Schulz, MD, PhD 2
, Ingrid Furlan, MD 2, Sandra Steinmann 2, Bernd Buchholz, PhD 3, Bernhard Kremens, MD 4, Claudia Rossig, MD 5, Selim Corbacioglu, MD 6, Revathi Rajagopal, MD 7, Georgia Lahr, PhD 2, Ayami Yoshimi 1, Brigitte Strahm, MD 1, Charlotte M. Niemeyer, PhD 1, Ansgar Schulz, MD, PhD 2 1 Division of Pediatric Hematology and Oncology, Department of Pediatrics and Adolescent Medicine, University of Freiburg, Freiburg, Germany
2 Department of Pediatrics and Adolescent Medicine, University Medical Center Ulm, Ulm, Germany
3 Department of Pediatrics, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany
4 Department of Pediatric Hematology and Oncology, University of Duisburg-Essen, Essen, Germany
5 Department of Pediatric Hematology and Oncology, University Children's Hospital Muenster, Muenster, Germany
6 Department of Pediatric Hematology, Oncology and Stem Cell Transplantation, University of Regensburg, Children's Hospital Regensburg, Regensburg, Germany
7 Pediatric Hematology-Oncology Unit, University of Malaya Medical Center, Kuala Lumpur, Malaysia
∗Reprint requests: Anne Strauss, Division of Pediatric Hematology and Oncology, Department of Pediatrics and Adolescent Medicine, University of Freiburg, Mathildenstrasse 1, 79106 Freiburg, Germany.
Abstract |
The initial clinical and hematologic presentation of infantile malignant osteopetrosis may be indistinguishable from that of juvenile myelomonocytic leukemia in infants. Timely radiographic imaging, however, allows straightforward delineation of these 2 severe diseases and facilitates immediate initiation of appropriate therapy.
Le texte complet de cet article est disponible en PDF.Keyword : IMO, JMML, LAD, PB, SCT, WAS
Plan
| The authors declare no conflict of interest. |
© 2015
Elsevier Inc. Tous droits réservés.
Vol 167 - N° 2
P. 486-488 - août 2015 Retour au numéro
Article précédent
- The Use of Gonadotropin-Releasing Hormone Analogs beyond Precocious Puberty
- Erica A. Eugster
- MORFAN Syndrome: An Infantile Hypoinsulinemic Hypoketotic Hypoglycemia Due to an AKT2 Mutation
- Nisha Garg, Guney Bademci, Joseph Foster, Zeynep S?klar, Merih Berberoglu, Mustafa Tekin
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?